Intelligence Platform

Patents

Browse 750 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 6262047

Selective factor Xa inhibitors

COR Therapeutics, Inc. · Granted Tue Jul 17 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6245743

Inhibitors of factor Xa

COR Therapeutics, Inc. · Granted Tue Jun 12 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6245560

Vector with multiple target response elements affecting gene expression

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jun 12 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6228854

Selective factor Xa inhibitors

COR Therapeutics, Inc. · Granted Tue May 08 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 03 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6228600

Immunoassays for the alpha platelet-derived growth factor receptor

The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 08 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 03 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6224879

Alphavirus expression vector

Bioption AB · Granted Tue May 01 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 26 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6225088

DNA encoding plasminogen-like growth factor (PLGF) and related embodiments

The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 01 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 26 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6218382

Selective factor Xa inhibitors

COR Therapeutics, Inc. · Granted Tue Apr 17 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6211183

Selective factor Xa inhibitors

COR Therapeutics, Inc. · Granted Tue Apr 03 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6211154

Ketoheterocyclic inhibitors of factor Xa

COR Therapeutics, Inc. · Granted Tue Apr 03 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6204268

Selective factor Xa inhibitors

COR Therapeutics, Inc. · Granted Tue Mar 20 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6200811

Cell transformation vector comprising an HIV-2 packaging site nucleic acid and an HIV-1 GA

The Regents of the University of California · Granted Tue Mar 13 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6197748

Ketoheterocyclic inhibitors of factor Xa

COR Therapeutics, Inc. · Granted Tue Mar 06 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6197578

Cells expressing both human CD4 and a human fusion accessory factor associated with HIV in

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Mar 06 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6194547

ETS2 repressor factor (ERF)

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 27 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6187313

Composition and method for treating and preventing helicobactor-pylori-associated stomach

Nature's Sunshine Products, Inc. · Granted Tue Feb 13 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6174862

Neurotrophic peptides of activity dependent neurotrophic factor

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jan 16 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 11 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6171855

Vectors

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jan 09 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 04 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6165781

Modified adeno-associated virus vector capable of expression from a novel promoter

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Dec 26 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6162620

Processes for the production of HCMV glycoproteins, antibodies thereto and HCMV vaccines,

Cogent Partners, LP · Granted Tue Dec 19 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6156321

Tissue factor methods and compositions for coagulation and tumor treatment

The Board of Regents of the University of Texas System · Granted Tue Dec 05 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6143714

Methods of using hepatocyte growth factor to promote survival, growth and differentiation

REGENERON PHARMACEUTICALS, INC. · Granted Tue Nov 07 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 02 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6132729

Combined tissue factor and chemotherapeutic methods and compositions for coagulation and t

The Board of Regents of the University of Texas System · Granted Tue Oct 17 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 12 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6133256

Selective factor Xa inhibitors

COR Therapeutics, Inc. · Granted Tue Oct 17 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 12 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired